PATENT CLAIM ANALYSIS

Application Number: 15768483
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "235800"]

Abstract:
Methods of the invention treat, reduce, or reverse fibrosis of a bodily tissue by administering to the local affected tissue a composition comprising an inhibitor of p38 MAP kinase, which treatment leads to a reduction or reversal of fibrosis.

Claim (Index 6):
The method of  claim 2 , wherein the small molecule inhibitor is selected from the group consisting of SB202190, SB 203580, SB 239063, SB 220025, SB 242235, BIRB-796, VX-702, VX-745, AMG-548, ARRY-797, PH 797804, ARRY-614, SB 681323; GW 856553, SCIO-469, BMS 582949, RO 4402257, and CNI-1493.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 91.0
- Lexical Diversity: 1.3871
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15319254', '14718933', '13445759', '15083370', '14943752']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7412997592523934
- 35 USC 102 Novelty (BERT): 0.5348313431478046
- Combined Prediction Score: 0.7206529176419346
- Mean Citation Score: 289.39753599999995
- Max Citation Score: 339.94452
- Similarity Product: 216.7126822693992

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test